This inventor holds 2 USPTO granted patents. Top assignees: Aventis Behring Gmbh, Tolerogen Ltd. Active years: 2003-2007.
Company Filing History:
Years Active: 2003-2007
Title: Werner Schlegel: Innovator in Allergy and Autoimmune Disease Treatment
Introduction
Werner Schlegel is a notable inventor based in Chancy, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of methods for treating allergic reactions and autoimmune diseases. With a total of 2 patents, Schlegel's work is recognized for its innovative approach to medical treatments.
Latest Patents
One of Schlegel's latest patents is a method for the production of conjugates and their uses for the prevention and treatment of allergic reactions and autoimmune diseases. This invention involves a detailed process that includes incubating a first polypeptide with a heterobifunctional crosslinker, followed by the removal of excess crosslinker and the incubation of the reaction product with a second polypeptide. The resulting conjugate can be used in pharmaceutical compositions aimed at preventing or treating allergic and autoimmune diseases.
Career Highlights
Throughout his career, Werner Schlegel has worked with prominent companies in the biotechnology sector, including Aventis Behring GmbH and Tolerogen Ltd. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Schlegel has collaborated with notable professionals in his field, including Yves Borel and Erwin W. Gelfand. These collaborations have likely enriched his research and development efforts, leading to advancements in his patented methods.
Conclusion
Werner Schlegel's contributions to the field of biotechnology, particularly in the treatment of allergic reactions and autoimmune diseases, highlight his role as an influential inventor. His innovative methods and collaborations continue to pave the way for advancements in medical treatments.